Formulary Search - PAD Formulary

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Pain (Neuropathic) (Pregabalin - Pain (Neuropathic))

Records returned : 12 (on 21 Nov 2024 at 13:31:41). Return to search results for ' Pain (Neuropathic) '.

Drug

Indication

Status

Trust Alignment

Links

Restrictions/Comments

04.07.03

04.07.04

04.08.01

Pregabalin

Pain (Neuropathic)

Green (see narrative)

Formulations :

Capsules

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

Important

Gabapentin is preferred due to lower potential for misuse. Pregabalin capsules more cost effective than tablets

04.07.03

04.07.04

04.08.01

Pain (Neuropathic)

Green (see narrative)

Formulations :

Oral solution

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

04.07.03

Duloxetine

Pain (Neuropathic)

Green

Formulations :

Capsules

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

Important

Licensed only for diabetic peripheral neuropathic pain but also recommended as per NICE CG173 (off- label indication) as a treatment option in neuropathic pain.

04.07.03

04.07.04

04.08.01

Gabapentin

Pain (Neuropathic)

Green

Formulations :

Capsules
Oral solution
Tablets

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

NICE

Important

First line gabapentinoid.

04.07.03

04.07.04

Amitriptyline hydrochloride

Pain (Neuropathic)

Green

Formulations :

Oral solution
Tablets

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

Preferred

04.07.02

Tramadol hydrochloride

Pain (Neuropathic)

Green (see narrative)

Formulations :

Capsules
Soluble tablets

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

Important

NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.

04.07.02

Pain (Neuropathic)

Green (see narrative)

Formulations :

Modified release capsules
Modified release tablets

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

Important

NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.

MR preparations to be prescribed by brand. Marol MR tablets are the locally preferred brand for primary care.

10.03.02

Capsaicin

Pain (Neuropathic)

Green (see narrative)

Formulations :

Cream

ASPH

RSFT

SASH

SABP

Primary Care

BNF NICE SPC

NICE

Important

For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)

0.075% cream (Axsain brand) is licensed for this indication

10.03.02

Pain (Neuropathic)

Red

Formulations :

Patches

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

Important

For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)

To be initiated by specialist pain care teams only

04.07.03

07.04.02

Imipramine hydrochloride

Pain (Neuropathic)

Non Formulary

Formulations :

Not Specified

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

04.07.03

Nortriptyline

Pain (Neuropathic)

Non Formulary

Formulations :

Not Specified

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

NFD1

04.07.03

Dosulepin hydrochloride

Pain (Neuropathic)

Non Formulary

Formulations :

Not Specified

ASPH

RSFT

SASH

SABP

Primary Care

BNF SPC

NFD1

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

ICB

Treatment commissioned by the ICB

BlueTeq

BlueTeq form to be completed

NICE

Traffic Light Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Black

Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.

Amber Star

Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)

See Below

Please add a description.

N/A

Please add a description.

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

Green - Black

Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.

See narrative

See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)

Do not initiate in new patients

These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)